(Q35034786)

5 August 2017

title

Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids (English)

1 reference

5 August 2017

0 references

1 reference

S Rice

3

0 references

Michael Berk

object named as

M Berk

7

0 references

author name string

G P Amminger

1

1 reference

5 August 2017

A Mechelli

2

1 reference

5 August 2017

S-W Kim

4

1 reference

5 August 2017

C M Klier

5

1 reference

5 August 2017

R K McNamara

6

1 reference

5 August 2017

P D McGorry

8

1 reference

5 August 2017

M R Schäfer

9

1 reference

5 August 2017

publication date

13 January 2015

1 reference

5 August 2017

published in

Translational Psychiatry

1 reference

5 August 2017

volume

5

1 reference

5 August 2017

page(s)

e495

1 reference

Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International

5 August 2017

copyright license

start time

1 January 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Meta-analysis of oxidative stress in schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312828

Red blood cell polyunsaturated fatty acids measured in red blood cells and schizophrenia: a meta-analysis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312828

Schizophrenia: linking prenatal infection to cytokines, the tryptophan catabolite (TRYCAT) pathway, NMDA receptor hypofunction, neurodevelopment and neuroprogression.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312828

Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312828

Eicosapentaenoic acid interventions in schizophrenia: meta-analysis of randomized, placebo-controlled studies

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312828

Using Support Vector Machine to identify imaging biomarkers of neurological and psychiatric disease: a critical review.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312828

Update on ω-3 polyunsaturated fatty acids in early-stage psychotic disorders

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312828

Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312828

At clinical high risk for psychosis: outcome for nonconverters

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312828

Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312828

Genetic variants in the metabolism of omega-6 and omega-3 fatty acids: their role in the determination of nutritional requirements and chronic disease risk

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312828

Dietary intake of fish, omega-3, omega-6 polyunsaturated fatty acids and vitamin D and the prevalence of psychotic-like symptoms in a cohort of 33,000 women from the general population

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312828

Niacin sensitivity and the arachidonic acid pathway in schizophrenia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312828

Randomized, placebo-controlled trial of flax oil in pediatric bipolar disorder

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312828

Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312828

Quantitative prediction of subjective pain intensity from whole-brain fMRI data using Gaussian processes

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312828

alpha-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312828

Omega-3 polyunsaturated fatty acids in the treatment of schizophrenia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312828

Brain foods: the effects of nutrients on brain function

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312828

Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312828

A neuroscientist's guide to lipidomics.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312828

Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312828

Bioactive lipids in schizophrenia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312828

Early-onset of symptoms predicts conversion to non-affective psychosis in ultra-high risk individuals

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312828

Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312828

Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312828

Joint modelling of longitudinal measurements and event time data.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312828

What is the role of alpha-linolenic acid for mammals?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312828

Restoring the DHA levels in the brains of Zellweger patients

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312828

Prediction of psychosis. A step towards indicated prevention of schizophrenia.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312828

The positive and negative syndrome scale (PANSS) for schizophrenia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312828

A New Depression Scale Designed to be Sensitive to Change

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312828

Omega-3 polyunsaturated fatty acid intake and islet autoimmunity in children at increased risk for type 1 diabetes

8 July 2018

1 reference

https://api.crossref.org/works/10.1038%2FTP.2014.134

The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTP.2014.134

Fish consumption and major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTP.2014.134

Long-term follow-up of a group at ultra high risk ("prodromal") for psychosis: the PACE 400 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTP.2014.134

Omega-3 fatty acid supplementation changes intracellular phospholipase A2 activity and membrane fatty acid profiles in individuals at ultra-high risk for psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTP.2014.134

Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTP.2014.134

Reduced red blood cell membrane essential polyunsaturated fatty acids in first episode schizophrenia at neuroleptic-naive baseline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTP.2014.134

A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTP.2014.134

Randomized, placebo-controlled study of ethyl-eicosapentaenoic acid as supplemental treatment in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTP.2014.134

Ethyl-eicosapentaenoic acid in first-episode psychosis. A 1H-MRS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTP.2014.134

Polyunsaturated fatty acids deficits are associated with psychotic state and negative symptoms in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTP.2014.134

PACE: a specialised service for young people at risk of psychotic disorders.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312828

Decreased nervonic acid levels in erythrocyte membranes predict psychosis in help-seeking ultra-high-risk individuals

25 October 2018

1 reference

https://api.crossref.org/works/10.1038%2FTP.2014.134

21 January 2018

Identifiers

DOI

10.1038/TP.2014.134

1 reference

5 August 2017

1 reference

5 August 2017

1 reference